The roles of long non-coding RNAs in Alzheimer's disease diagnosis, treatment, and their involvement in Alzheimer's disease immune responses

被引:7
作者
Wu, Xiaoben [1 ]
Xia, Pengcheng [1 ]
Yang, Lei [2 ]
Lu, Chao [1 ]
Lu, Zhiming [1 ]
机构
[1] Shandong First Med Univ, Shandong Prov Hosp, Dept Clin Lab, Jinan, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Med Engn, Jinan, Peoples R China
来源
NON-CODING RNA RESEARCH | 2024年 / 9卷 / 03期
关键词
Alzheimer's disease; Long non -coding RNA; Diagnosis; Treatment; Progression; NEURODEGENERATIVE DISEASES; EPIGENETIC REGULATORS; INNATE IMMUNITY; NEAT1; TARGET; ACTIVATION; MECHANISMS; BIOMARKERS; BC200; MICE;
D O I
10.1016/j.ncrna.2024.03.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is the most frequent type of dementia, presenting a substantial danger to the health and well-being of the aged population. It has arisen as a significant public health problem with considerable socioeconomic repercussions. Unfortunately, no effective treatments or diagnostic tools are available for Alzheimer's disease. Despite substantial studies on the pathophysiology of Alzheimer's, the molecular pathways underpinning its development remain poorly understood. Long non-coding RNAs (lncRNAs) vary in size from 200 nucleotides to over 100 kilobytes and have been found to play critical roles in various vital biological processes that play critical in developing Alzheimer's disease. This review intends to examine the functions of long non-coding RNAs in diagnosing and treating Alzheimer's disease and their participation in immunological responses associated with AD.
引用
收藏
页码:659 / 666
页数:8
相关论文
共 83 条
[1]   A Single Cell but Many Different Transcripts: A Journey into the World of Long Non-Coding RNAs [J].
Alessio, Enrico ;
Bonadio, Raphael Severino ;
Buson, Lisa ;
Chemello, Francesco ;
Cagnin, Stefano .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
[2]   The Perspective of Dysregulated LncRNAs in Alzheimer's Disease: A Systematic Scoping Review [J].
Asadi, Mohammad Reza ;
Hassani, Mehdi ;
Kiani, Shiva ;
Sabaie, Hani ;
Moslehian, Marziyeh Sadat ;
Kazemi, Mohammad ;
Ghafouri-Fard, Soudeh ;
Taheri, Mohammad ;
Rezazadeh, Maryam .
FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
[3]   Antisense Drugs Make Sense for Neurological Diseases [J].
Bennett, C. Frank ;
Kordasiewicz, Holly B. ;
Cleveland, Don W. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021, 2021, 61 :831-852
[4]   Biomarker definitions and their applications [J].
Califf, Robert M. .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 243 (03) :213-221
[5]   MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis [J].
Chang, Hua ;
Zhang, Xue ;
Li, Baixue ;
Meng, Xiangkai .
CANCER MEDICINE, 2020, 9 (17) :6377-6386
[6]   Relationship between long non-coding RNAs and Alzheimer's disease: a systematic review [J].
Chen, Lijuan ;
Guo, XiaoBing ;
Li, Zhengtao ;
He, Yongsheng .
PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (01) :12-20
[7]   Suppression of MALAT1 ameliorates chronic constriction injury-induced neuropathic pain in rats via modulating miR-206 and ZEB2 [J].
Chen, Zhao-Ling ;
Liu, Jing-Yi ;
Wang, Fang ;
Jing, Xu .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (09) :15647-15653
[8]   An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples [J].
Ciarlo, Eleonora ;
Massone, Sara ;
Penna, Ilaria ;
Nizzari, Mario ;
Gigoni, Arianna ;
Dieci, Giorgio ;
Russo, Claudio ;
Florio, Tullio ;
Cancedda, Ranieri ;
Pagano, Aldo .
DISEASE MODELS & MECHANISMS, 2013, 6 (02) :424-433
[9]   Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease [J].
Cortini, Francesca ;
Roma, Francesca ;
Villa, Chiara .
AGEING RESEARCH REVIEWS, 2019, 50 :19-26
[10]   The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases [J].
DeMaio, Alexa ;
Mehrotra, Shikhar ;
Sambamurti, Kumar ;
Husain, Shahid .
JOURNAL OF NEUROINFLAMMATION, 2022, 19 (01)